Publication Information

{'id': 'https://openalex.org/W2273124893', 'doi': 'https://doi.org/10.1007/s00280-015-2931-4', 'title': 'A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities', 'display_name': 'A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities', 'publication_year': 2016, 'publication_date': '2016-01-25', 'ids': {'openalex': 'https://openalex.org/W2273124893', 'doi': 'https://doi.org/10.1007/s00280-015-2931-4', 'mag': '2273124893', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/26811176', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/4767861'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1007/s00280-015-2931-4', 'pdf_url': 'https://link.springer.com/content/pdf/10.1007%2Fs00280-015-2931-4.pdf', 'source': {'id': 'https://openalex.org/S117498271', 'display_name': 'Cancer Chemotherapy and Pharmacology', 'issn_l': '0344-5704', 'issn': ['0344-5704', '1432-0843'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'https://link.springer.com/content/pdf/10.1007%2Fs00280-015-2931-4.pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5011946503', 'display_name': 'Dan Lü', 'orcid': 'https://orcid.org/0000-0003-4531-3599'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dan Lu', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101625676', 'display_name': 'Tong Lu', 'orcid': 'https://orcid.org/0009-0005-5368-5319'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Tong Lu', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5062831066', 'display_name': 'Mark Stroh', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mark Stroh', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111983289', 'display_name': 'Richard Graham', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210133216', 'display_name': 'Theravance Biopharma (United States)', 'ror': 'https://ror.org/03a6z4w08', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210133216']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richard A. Graham', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, Theravance Biopharma U.S., Inc., South San Francisco, CA, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, Theravance Biopharma U.S., Inc., South San Francisco, CA, USA', 'institution_ids': ['https://openalex.org/I4210133216']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082723850', 'display_name': 'Priya Agarwal', 'orcid': 'https://orcid.org/0000-0002-0779-1509'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Priya Agarwal', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022619396', 'display_name': 'Luna Musib', 'orcid': 'https://orcid.org/0000-0002-6476-7919'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Luna Musib', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5089004534', 'display_name': 'Chi‐Chung Li', 'orcid': 'https://orcid.org/0000-0002-9590-3450'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Chi-Chung Li', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110076874', 'display_name': 'Bert L. Lum', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bert L. Lum', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5064009743', 'display_name': 'Amita Joshi', 'orcid': 'https://orcid.org/0009-0006-0017-2971'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Amita Joshi', 'raw_affiliation_strings': ['Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Clinical Pharmacology, Genentech, Inc., 1 DNA Way, MS 463A, South San Francisco, CA, 94080, USA', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3290, 'currency': 'EUR', 'value_usd': 3990, 'provenance': 'doaj'}, 'apc_paid': {'value': 3290, 'currency': 'EUR', 'value_usd': 3990, 'provenance': 'doaj'}, 'fwci': 0.938, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 47, 'citation_normalized_percentile': {'value': 0.998635, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '77', 'issue': '3', 'first_page': '459', 'last_page': '476'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11287', 'display_name': 'Cancer Genomics and Diagnostics', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11287', 'display_name': 'Cancer Genomics and Diagnostics', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12708', 'display_name': 'Economic and Financial Impacts of Cancer', 'score': 0.9954, 'subfield': {'id': 'https://openalex.org/subfields/2002', 'display_name': 'Economics and Econometrics'}, 'field': {'id': 'https://openalex.org/fields/20', 'display_name': 'Economics, Econometrics and Finance'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, {'id': 'https://openalex.org/T13417', 'display_name': 'Biomedical Ethics and Regulation', 'score': 0.9937, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/postmarketing-surveillance', 'display_name': 'Postmarketing surveillance', 'score': 0.48213077}, {'id': 'https://openalex.org/keywords/drug-approval', 'display_name': 'Drug approval', 'score': 0.48131073}, {'id': 'https://openalex.org/keywords/drug-development', 'display_name': 'Drug Development', 'score': 0.47404575}, {'id': 'https://openalex.org/keywords/precision-oncology', 'display_name': 'Precision oncology', 'score': 0.45260468}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.66350675}, {'id': 'https://openalex.org/C197636746', 'wikidata': 'https://www.wikidata.org/wiki/Q7234359', 'display_name': 'Postmarketing surveillance', 'level': 3, 'score': 0.48213077}, {'id': 'https://openalex.org/C2992293740', 'wikidata': 'https://www.wikidata.org/wiki/Q4781752', 'display_name': 'Drug approval', 'level': 3, 'score': 0.48131073}, {'id': 'https://openalex.org/C64903051', 'wikidata': 'https://www.wikidata.org/wiki/Q2198549', 'display_name': 'Drug development', 'level': 3, 'score': 0.47404575}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.47212586}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.46024507}, {'id': 'https://openalex.org/C192209626', 'wikidata': 'https://www.wikidata.org/wiki/Q190909', 'display_name': 'Focus (optics)', 'level': 2, 'score': 0.45974877}, {'id': 'https://openalex.org/C3020497934', 'wikidata': 'https://www.wikidata.org/wiki/Q17075943', 'display_name': 'Precision oncology', 'level': 3, 'score': 0.45260468}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.44979125}, {'id': 'https://openalex.org/C19527891', 'wikidata': 'https://www.wikidata.org/wiki/Q1120908', 'display_name': 'Medical physics', 'level': 1, 'score': 0.36961657}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3273274}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.17242998}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.15953746}, {'id': 'https://openalex.org/C121332964', 'wikidata': 'https://www.wikidata.org/wiki/Q413', 'display_name': 'Physics', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C120665830', 'wikidata': 'https://www.wikidata.org/wiki/Q14620', 'display_name': 'Optics', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D017277', 'descriptor_name': 'Drug Approval', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020714', 'descriptor_name': 'Maximum Tolerated Dose', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D058990', 'descriptor_name': 'Molecular Targeted Therapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D011358', 'descriptor_name': 'Product Surveillance, Postmarketing', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014481', 'descriptor_name': 'United States', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014486', 'descriptor_name': 'United States Food and Drug Administration', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 3, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1007/s00280-015-2931-4', 'pdf_url': 'https://link.springer.com/content/pdf/10.1007%2Fs00280-015-2931-4.pdf', 'source': {'id': 'https://openalex.org/S117498271', 'display_name': 'Cancer Chemotherapy and Pharmacology', 'issn_l': '0344-5704', 'issn': ['0344-5704', '1432-0843'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767861', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/26811176', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1007/s00280-015-2931-4', 'pdf_url': 'https://link.springer.com/content/pdf/10.1007%2Fs00280-015-2931-4.pdf', 'source': {'id': 'https://openalex.org/S117498271', 'display_name': 'Cancer Chemotherapy and Pharmacology', 'issn_l': '0344-5704', 'issn': ['0344-5704', '1432-0843'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.68, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 18, 'referenced_works': ['https://openalex.org/W1501566740', 'https://openalex.org/W1977180561', 'https://openalex.org/W1986188871', 'https://openalex.org/W2024447346', 'https://openalex.org/W2064651476', 'https://openalex.org/W2086061321', 'https://openalex.org/W2089137624', 'https://openalex.org/W2091666474', 'https://openalex.org/W2098461478', 'https://openalex.org/W2100738068', 'https://openalex.org/W2112196468', 'https://openalex.org/W2113038732', 'https://openalex.org/W2114991862', 'https://openalex.org/W2115125611', 'https://openalex.org/W2123709211', 'https://openalex.org/W2416957871', 'https://openalex.org/W2600384146', 'https://openalex.org/W850470413'], 'related_works': ['https://openalex.org/W3165404536', 'https://openalex.org/W3010700640', 'https://openalex.org/W2588798634', 'https://openalex.org/W2338367129', 'https://openalex.org/W2171223526', 'https://openalex.org/W2093398530', 'https://openalex.org/W2036983269', 'https://openalex.org/W2034858584', 'https://openalex.org/W2029342376', 'https://openalex.org/W1502809559'], 'abstract_inverted_index': {'The': [0, 97], 'maximally': [1], 'tolerated': [2], 'dose': [3, 19, 124, 163, 188], '(MTD)': [4], 'of': [5, 41, 70, 78, 139, 171, 176, 193], 'cytotoxic': [6], 'agents': [7, 63, 102], 'has': [8], 'historical': [9], 'precedence': [10], 'in': [11, 117], 'treating': [12], 'cancer,': [13], 'as': [14], 'it': [15], 'was': [16], 'believed': [17], 'that': [18, 27, 121], 'and': [20, 26, 113, 115, 125, 148, 160, 195], 'therapeutic': [21, 33, 57], 'effect': [22], 'are': [23, 66], 'intrinsically': [24], 'linked': [25], 'the': [28, 39, 107, 122, 140, 144, 162, 169, 172, 177, 181, 191], 'MTD': [29, 173], 'would': [30], 'provide': [31], 'greatest': [32], 'value.': [34], 'With': [35], 'molecularly': [36], 'targeted': [37, 62, 101], 'agents,': [38], 'premise': [40], 'preventing': [42], 'toxicity': [43], 'to': [44, 91, 104, 143, 174, 187], 'normal': [45], 'tissues': [46], 'while': [47], 'modulating': [48], 'tumor': [49], 'growth': [50], 'provides': [51, 135], 'a': [52, 136], 'potential': [53], 'for': [54, 127, 152, 166], 'an': [55, 68], 'increased': [56], 'window.': [58], 'Results': [59], 'from': [60, 86, 155], 'these': [61, 100], 'suggest': [64], 'we': [65], 'entering': [67], 'era': [69], 'chronic': [71], 'cancer': [72], 'management,': [73], 'which': [74], 'will': [75], 'require': [76], 'design': [77], 'regimens': [79], 'with': [80, 99], 'long-term': [81], 'tolerability.': [82], 'A': [83], 'corresponding': [84], 'switch': [85], 'MTD-based': [87], '(toxicity-driven)': [88], 'dosing': [89], 'strategies': [90], 'alternative': [92], 'paradigms': [93], 'is': [94, 103], 'also': [95], 'expected.': [96], 'challenge': [98], 'fully': [105], 'understand': [106], 'complex': [108], 'relationship': [109, 170], 'between': [110], 'pharmacokinetics,': [111], 'pharmacodynamics,': [112], 'safety': [114], 'efficacy': [116], 'early-stage': [118], 'trials,': [119, 168], 'so': [120], 'optimal': [123], 'schedule': [126], 'registration': [128], 'trials': [129], 'may': [130], 'be': [131], 'identified.': [132], 'This': [133], 'review': [134], 'systematic': [137], 'survey': [138], 'applications': [141], 'submitted': [142], 'United': [145], 'States': [146], 'Food': [147], 'Drug': [149], 'Administration': [150], '(FDA)': [151], 'oncology': [153], 'indications,': [154], '2010': [156], 'through': [157], 'early': [158], '2015,': [159], 'summarizes': [161], 'selection': [164], 'rationale': [165], 'registrational': [167], 'outcomes': [175], 'final': [178], 'label': [179], 'dose,': [180], 'postmarketing': [182], 'requirements': [183], 'or': [184], 'commitments': [185], 'related': [186], 'optimization': [189], 'activities,': [190], 'role': [192], 'biomarkers,': [194], 'typical': [196], 'exposure-response': [197], 'modeling': [198], 'methods.': [199]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2273124893', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 5}, {'year': 2021, 'cited_by_count': 4}, {'year': 2020, 'cited_by_count': 8}, {'year': 2019, 'cited_by_count': 7}, {'year': 2018, 'cited_by_count': 5}, {'year': 2017, 'cited_by_count': 10}, {'year': 2016, 'cited_by_count': 4}], 'updated_date': '2024-12-12T22:36:56.722737', 'created_date': '2016-06-24'}